RRM1 expression is associated with the outcome of gemcitabine-based treatment of non-small cell lung cancer patients–a short report


RRM1 is the large subunit of ribonucleotide reductase (RNR), which catalyzes the rate-limiting step in the production of deoxyribonucleotides (dNTPs) and is essential for DNA synthesis and repair. Through a meta-analysis of observational studies, we evaluated whether RRM1 expression levels are associated with the clinical outcome of gemcitabine-containing… (More)
DOI: 10.1007/s13402-015-0225-9


5 Figures and Tables